Thomas R. Kuhn - 22 Jan 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Director, Chairman
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Issuer symbol
ATEX
Transactions as of
22 Jan 2025
Net transactions value
$0
Form type
4
Filing time
24 Jan 2025, 17:24:51 UTC
Previous filing
14 Jan 2025
Next filing
16 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +56,803 $0.000000 56,803 22 Jan 2025 Common Stock 56,803 $29.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest in full and become exercisable on January 22, 2028, subject to the Reporting Person's continued service with the Issuer through this date.